These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Exercises using the upper limbs hyperinflate COPD patients more than exercises using the lower limbs at the same metabolic demand. Porto EF; Castro AA; Velloso M; Nascimento O; Dal Maso F; Jardim JR Monaldi Arch Chest Dis; 2009 Mar; 71(1):21-6. PubMed ID: 19522161 [TBL] [Abstract][Full Text] [Related]
45. Cardiorespiratory and muscle oxygenation responses to low-load/high-repetition resistance exercises in COPD and healthy controls. Nyberg A; Saey D; Martin M; Maltais F J Appl Physiol (1985); 2018 Apr; 124(4):877-887. PubMed ID: 29357500 [TBL] [Abstract][Full Text] [Related]
46. Abnormal transition pore kinetics and cytochrome C release in muscle mitochondria of patients with chronic obstructive pulmonary disease. Puente-Maestu L; Pérez-Parra J; Godoy R; Moreno N; Tejedor A; Torres A; Lázaro A; Ferreira A; Agustí A Am J Respir Cell Mol Biol; 2009 Jun; 40(6):746-50. PubMed ID: 19011161 [TBL] [Abstract][Full Text] [Related]
48. The major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles vs. lower limb muscle dysfunction vs. dynamic hyperinflation. Measurements, estimates, interpretations, myths. Jones NL J Appl Physiol (1985); 2008 Aug; 105(2):759-60. PubMed ID: 18770880 [No Abstract] [Full Text] [Related]
49. The major limitation to exercise performance in COPD is lower limb muscle dysfunction. Debigaré R; Maltais F J Appl Physiol (1985); 2008 Aug; 105(2):751-3; discussion 755-7. PubMed ID: 18678623 [No Abstract] [Full Text] [Related]
50. Evidence that a higher ATP cost of muscular contraction contributes to the lower mechanical efficiency associated with COPD: preliminary findings. Layec G; Haseler LJ; Hoff J; Richardson RS Am J Physiol Regul Integr Comp Physiol; 2011 May; 300(5):R1142-7. PubMed ID: 21307358 [TBL] [Abstract][Full Text] [Related]
51. The role of MicroRNAs in COPD muscle dysfunction and mass loss: implications on the clinic. Barreiro E Expert Rev Respir Med; 2016 Sep; 10(9):1011-22. PubMed ID: 27348064 [TBL] [Abstract][Full Text] [Related]
52. Muscular and functional effects of partitioning exercising muscle mass in patients with chronic obstructive pulmonary disease - a study protocol for a randomized controlled trial. Nyberg A; Saey D; Martin M; Maltais F Trials; 2015 Apr; 16():194. PubMed ID: 25927288 [TBL] [Abstract][Full Text] [Related]
53. Assessing upper-extremity motion: An innovative method to quantify functional capacity in patients with chronic obstructive pulmonary disease. Toosizadeh N; Berry C; Bime C; Najafi B; Kraft M; Mohler J PLoS One; 2017; 12(2):e0172766. PubMed ID: 28235045 [TBL] [Abstract][Full Text] [Related]
54. High oxygen extraction and slow recovery of muscle deoxygenation kinetics after neuromuscular electrical stimulation in COPD patients. Azevedo Dde P; Medeiros WM; de Freitas FF; Ferreira Amorim C; Gimenes AC; Neder JA; Chiavegato LD Eur J Appl Physiol; 2016 Oct; 116(10):1899-910. PubMed ID: 27468840 [TBL] [Abstract][Full Text] [Related]
55. Effect of different form of upper limb muscles training on dyspnea in chronic obstructive pulmonary disease: A study protocol. Beaumont M; Péran L; Berriet AC; Le Ber C; Le Mevel P; Courtois-Communier E; Couturaud F Medicine (Baltimore); 2020 Sep; 99(38):e22131. PubMed ID: 32957334 [TBL] [Abstract][Full Text] [Related]
56. Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD. Gosker HR; Hesselink MK; Duimel H; Ward KA; Schols AM Eur Respir J; 2007 Jul; 30(1):73-9. PubMed ID: 17428811 [TBL] [Abstract][Full Text] [Related]
57. Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Agustí AG; Sauleda J; Miralles C; Gomez C; Togores B; Sala E; Batle S; Busquets X Am J Respir Crit Care Med; 2002 Aug; 166(4):485-9. PubMed ID: 12186825 [TBL] [Abstract][Full Text] [Related]
58. Genetic variants predicting aerobic capacity response to training are also associated with skeletal muscle oxidative capacity in moderate-to-severe COPD. Adami A; Hobbs BD; McDonald MN; Casaburi R; Rossiter HB; Physiol Genomics; 2018 Sep; 50(9):688-690. PubMed ID: 29799805 [TBL] [Abstract][Full Text] [Related]
59. Effects of upper limb resistance exercise on aerobic capacity, muscle strength, and quality of life in COPD patients: a randomized controlled trial. Silva CMDSE; Gomes Neto M; Saquetto MB; Conceição CSD; Souza-Machado A Clin Rehabil; 2018 Dec; 32(12):1636-1644. PubMed ID: 30012033 [TBL] [Abstract][Full Text] [Related]
60. Clinical importance of cross-sectional area of intercostal muscles in patients with chronic obstructive pulmonary disease. Ju S; Lee SJ; Park MJ; Cho YJ; Jeong YY; Jeon KN; Bae K; Lee JD; Kim HC Clin Respir J; 2018 Mar; 12(3):939-947. PubMed ID: 28054460 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]